Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?

por Bloch, Michael J.
Publicado 2020

Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data

por Bronander, Kirk A, Bloch, Michael J
Publicado 2007

Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial

por Azizi, Michel, Mahfoud, Felix, Weber, Michael A., Sharp, Andrew S. P., Schmieder, Roland E., Lurz, Philipp, Lobo, Melvin D., Fisher, Naomi D. L., Daemen, Joost, Bloch, Michael J., Basile, Jan, Sanghvi, Kintur, Saxena, Manish, Gosse, Philippe, Jenkins, J. Stephen, Levy, Terry, Persu, Alexandre, Kably, Benjamin, Claude, Lisa, Reeve-Stoffer, Helen, McClure, Candace, Kirtane, Ajay J.
Publicado 2022

Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study

por Saxena, Manish, Schmieder, Roland E., Kirtane, Ajay J., Mahfoud, Felix, Daemen, Joost, Basile, Jan, Lurz, Philipp, Gosse, Philippe, Sanghvi, Kintur, Fisher, Naomi D. L., Rump, Lars C., Pathak, Atul, Blankestijn, Peter J., Mathur, Anthony, Wang, Yale, Weber, Michael A., Sharp, Andrew S. P., Bloch, Michael J., Barman, Neil C., Claude, Lisa, Song, Yang, Azizi, Michel, Lobo, Melvin D.
Publicado 2021

Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials

por Kirtane, Ajay J., Sharp, Andrew S. P., Mahfoud, Felix, Fisher, Naomi D. L., Schmieder, Roland E., Daemen, Joost, Lobo, Melvin D., Lurz, Philipp, Basile, Jan, Bloch, Michael J., Weber, Michael A., Saxena, Manish, Wang, Yale, Sanghvi, Kintur, Jenkins, J. Stephen, Devireddy, Chandan, Rader, Florian, Gosse, Philippe, Sapoval, Marc, Barman, Neil C., Claude, Lisa, Augustin, Dimitri, Thackeray, Lisa, Mullin, Christopher M., Azizi, Michel
Publicado 2023